Signal active
Organization
Contact Information
Overview
CellCentric’s primary programme targets a deubiquitinase (DUB) enzyme which is strongly associated with prostate cancer, a leading cause of mortality among men. The target modulates the androgen receptor pathway and can potentially combat the multiple resistance mechanisms seen with recently approved prostate cancer drugs such Xtandi and Zytiga.
The programme also has potential clinical utility in non-small cell lung, breast and colon cancer.
About
Biotechnology, Medical, Therapeutics
2003
1-10
Headquarters locations
Cambridge, Cambridgeshire, United Kingdom, Europe
Social
Profile Resume
CellCentric headquartered in Europe, operates in the Biotechnology, Medical, Therapeutics sector. The company focuses on Biotechnology and has secured $29.3B in funding across 216 round(s). With a team of 1-10 employees, CellCentric is actively contributing to advancements in Biotechnology. Their latest funding round, Venture Round - CellCentric, raised $6.6M. Discover more about their projects, partnerships, and impact on our platform.
Funding Rounds
18
4
0
$135.6M
Details
2
CellCentric has raised a total of $135.6M in funding over 2 rounds.
Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
---|---|---|---|---|
2011 | Early Stage Venture | |||
2004 | Early Stage Venture |
Investors
CellCentric is funded by 45 investors.
Investor Name | Lead Investor | Funding Round | Partners |
---|---|---|---|
5Y Capital | - | FUNDING ROUND - 5Y Capital | 6.6M |
UK Innovation & Science Seed Fund | - | FUNDING ROUND - UK Innovation & Science Seed Fund | 6.6M |
CellCentric | - | FUNDING ROUND - CellCentric | 6.6M |
Future Planet Capital | - | FUNDING ROUND - Future Planet Capital | 6.6M |
Recent Activity
Funding Round
Jul 24, 2024
CellCentric raised $34998918 on 2024-07-24 in Venture Round
Funding Round
Jul 11, 2023
CellCentric raised $25000000 on 2023-07-11 in Corporate Round
Funding Round
Jan 26, 2022
CellCentric raised an undisclosed amount on 2022-01-26 in Venture Round
Funding Round
Oct 22, 2020
CellCentric raised $33000000 on 2020-10-22 in Venture Round
Funding Round
May 15, 2018
CellCentric raised $26000000 on 2018-05-15 in Venture Round